Establishment Labs Holdings Inc's stock had its IPO on July 19, 2018, making it an older stock than merely 6.14% of US equities in our set.
ESTA's price/sales ratio is 7.77; that's higher than the P/S ratio of 81.57% of US stocks.
Establishment Labs Holdings Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is -10.15%, greater than the shareholder yield of only 23.4% of stocks in our set.
Stocks with similar financial metrics, market capitalization, and price volatility to Establishment Labs Holdings Inc are OPTN, STIM, VAPO, PWFL, and TELA.
Establishment Labs Holdings Inc. (ESTA) Company Bio
Establishment Labs Holdings Inc., a medical technology company, designs, develops, manufactures, and markets medical devices for aesthetic plastic surgery, reconstructive plastic surgery, and aesthetic dermatology. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Divina 3D simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and distributes Puregraft line of products that is used to remove blood, lipids, and other components from adipose tissue. The company sells its products through exclusive distributors and direct sales force in 60 countries worldwide. The company was founded in 2004 and is based in Alajuela, Costa Rica.
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filings submitted by hedge funds and prominent investors. These filings show these funds' portfolio positions as of March 31st, 2020. […]
Establishment Labs Holdings Inc. (ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced it has received CE Mark for the Motiva Flora Tissue Expander. “Unlike traditional tissue expanders with magnetic ports, a patient with a Motiva Flora Tissue Expander can be safely scanned immediately after placement using MR systems operating at 1.5- or 3-Tesla,” said Frank G. Shellock, Ph.D., Adjunct Clinical Professor of Radiology and Medicine, and Director of MRI Safety, University of Southern California, and author of the widely used Reference Manual for Magnetic Resonance Safety, Implants, and Devices.